- Fellowship - University of Iowa Hospitals and Clinics (2011-2014), Gynecologic Oncology
- Medical School - University of Nebraska College of Medicine (2003-2007)
- Residency - Ohio State University, Columbus (2007-2011), Obstetrics & Gynecology
Matthew Carlson, M.D.
- Obstetrics & Gynecology - Gyn Oncology
- Peritoneal Cancer
- Cervical Cancer
Dr. Carlson received his undergraduate degree in chemistry from Creighton University in 2001. He attended the University of Miami and received a Master of Science in chemistry in 2003 before earning his medical degree at the University of Nebraska College of Medicine in 2007. He completed his residency in obstetrics and gynecology at The Ohio State University Medical Center and then pursued advanced training in gynecologic oncology through a fellowship at the University of Iowa Hospitals and Clinics. He joined UT Southwestern in 2014.
Dr. Carlson serves on two committees for the Society of Gynecologic Oncology and is a co-investigator with the Gynecologic Oncology Group, among other professional activities. During his education and training, Dr. Carlson was recognized with numerous awards and honors, including the Arnold P. Gold Foundation Humanism Award, given to six residents for excellence in medical student education.
His research in endometrial cancer has been published in the journals Gynecologic Oncology and Obstetrics and Gynecology. At UT Southwestern, his research focuses on the quality and cost effectiveness of cancer care.
Meet Dr. Carlson
Gynecologic Cancer Specialist in Dallas
Gynecologic cancer specialist Matthew Carlson, M.D., focuses on cancers of the female reproductive tract, including vulvar, vaginal, cervical, ovarian, and uterine/endometrial cancers. He is a skilled minimally invasive and robotic surgeon with expertise in the most advanced chemotherapies and targeted drugs.
Gynecologic oncologists are unique among oncologists. They are surgeons as well as medical doctors, meaning they handle all aspects of a woman’s gynecologic cancer needs – from diagnosis to drug therapies and surgical treatment.
Dr. Carlson says his range of skills allows him to treat the “whole patient” in every situation, not just the disease. He takes into account all aspects of his patients’ health and lives when he recommends a care plan, from their weight or family situation to where they live in relation to the medical center.
“Every factor can make a difference in the healing process,” he says. “It’s not just what happens when they’re in my office or in the operating room.”
Dr. Carlson’s holistic approach extends to how he and his gynecologic cancer colleagues at UT Southwestern Medical Center interact. They meet formally every week to discuss patient cases, and they constantly share ideas and treatment strategies, challenging each other to see things from every perspective.
“Our group of doctors is special because we have a variety of experience and a variety of training backgrounds, so we all bring unique insight that we’re able to translate into the best care for our patients,” he says.
In his research, Dr. Carlson focuses on the quality and cost effectiveness of care, as well as the genetic factors that play a role in gynecologic cancers.
Hypoalbuminemia is a Predictive Factor for Fistula Formation in Recurrent Cervical Cancer.
Palavalli Parsons LH, Roane B, Manders DB, Richardson DL, Kehoe SM, Carlson M, Miller DS, Lea JS American journal of clinical oncology 2017 Aug
The Sign of Leser-Trelát and Malignant Acanthosis Nigricans Associated With Fallopian Tube Carcinoma.
West L, Carlson M, Wallis L, Goff HW Obstetrics and gynecology 2018 Oct
Emphasis on Systemic Therapy in Women With Pelvic Bone Metastasis at Time of Diagnosis of Cervical Cancer.
Manders DB, Sims TT, Albuquerque KV, Carlson MJ, Richardson DL, Kehoe SM, Miller DS, Lea JS American journal of clinical oncology 2018 Mar
The opinions and practices of providers toward the sexual issues of cervical cancer patients undergoing treatment.
Bedell S, Manders D, Kehoe S, Lea J, Miller D, Richardson D, Carlson M, Gynecologic oncology 2017 03 144 3 586-591
- Hypoalbuminemia is a Predictive Factor for Fistula Formation in Recurrent Cervical Cancer.
- Peritoneal Cancer
- Cervical Cancer
- Ovarian Cancer
- Uterine Cancer
- Vaginal Cancer
- Vulvar Cancer
- Medical Treatment of Gynecologic Cancer
- Surgical Treatment for Gynecologic Cancer
- Gestational Trophoblastic Disease
- Gynecologic Cancers